MIRM
Mirum Pharmaceuticals, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones +6.5% · nuevas posiciones netas 0.0% — fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 106 | +2 | 35.68M | $4.18B | +9 | −7 |
| Q1 2026 | 107 | +6 | 39.52M | $3.63B | +12 | −7 |
| Q4 2025 | 102 | +1 | 36.05M | $2.83B | +2 | — |
| Q3 2025 | 20 | 0 | 17.64M | $1.29B | — | — |
| Q2 2025 | 17 | +1 | 13.61M | $692.65M | +2 | −1 |
| Q1 2025 | 13 | +1 | 7.45M | $335.67M | +2 | −1 |
| Q4 2024 | 12 | 0 | 6.63M | $274.04M | +1 | −1 |
| Q3 2024 | 11 | +2 | 4.84M | $188.84M | +2 | — |
| Q2 2024 | 9 | — | 4.39M | $149.94M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Citadel Advisors ✦ | 1.51M | +8.6% | $62.49M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 2 | Citadel Advisors ✦ | 1.51M | +8.6% | $62.49M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 1.42M | +10.8% | $58.83M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 1.42M | +10.8% | $58.83M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | State Street Global Advisors ✦ (pasivo) | 1.38M | — | $57.13M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Geode Capital Management ✦ (pasivo) | 943.34K | +0.8% | $39.02M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Geode Capital Management ✦ (pasivo) | 943.34K | +0.8% | $39.02M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Millennium Management ✦ | 526.97K | +15.7% | $21.79M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | Marshall Wace ✦ | 175.91K | +641.6% | $7.27M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | Marshall Wace ✦ | 175.91K | +641.6% | $7.27M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 157.35K | Nuevo | $6.51M | 0.0% | New | 1 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 157.35K | Nuevo | $6.51M | 0.0% | New | 1 | SEC ↗ |
| 13 | Adage Capital Partners ✦ | 150.00K | +87.5% | $6.20M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Two Sigma Investments ✦ | 126.45K | -44.4% | $5.23M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | Wellington Management ✦ | 118.20K | -3.4% | $4.89M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | Wellington Management ✦ | 118.20K | -3.4% | $4.89M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | Wellington Management ✦ | 118.20K | -3.4% | $4.89M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Wellington Management ✦ | 118.20K | -3.4% | $4.89M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Renaissance Technologies ✦ | 101.25K | +67.5% | $4.19M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 12.05K | -4.0% | $498,185 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 12.05K | -4.0% | $498,185 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 12.05K | -4.0% | $498,185 | 0.0% | ▼ Trim | 3 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| D. E. Shaw & Co. | $6.51M | 0.0% |
| D. E. Shaw & Co. | $6.51M | 0.0% |
Posición cerrada
| Norges Bank | $9.68M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 308 tenedores, 67.83M acciones, $6.01B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer · 40.00K acc. · $4.00M
Officer · 6.00K acc. · $599,510
Officer, Director · 11.68K acc. · $1.15M
Officer, Director · 6.02K acc. · $597,187
Officer, Director · 2.30K acc. · $230,322
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología